Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
about
Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor CellsFibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.Logic Learning Machine and standard supervised methods for Hodgkin's lymphoma prognosis using gene expression data and clinical variables.Macrophages facilitate coal tar pitch extract-induced tumorigenic transformation of human bronchial epithelial cells mediated by NF-κB.Macrophages and dendritic cells as actors in the immune reaction of classical Hodgkin lymphomaDifference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors.CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma.CD163 versus CD68 in tumor associated macrophages of classical Hodgkin lymphoma.Leukocyte composition of human breast cancerImmunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphoma.Meta-analysis of the prognostic and clinical value of tumor-associated macrophages in adult classical Hodgkin lymphoma.Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trialCD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma.CD163 and c-Met expression in the lymph node and the correlations between elevated levels of serum free light chain and the different clinicopathological parameters of advanced classical Hodgkin's lymphoma.Identification and manipulation of tumor associated macrophages in human cancers.The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities.Role of tumor-associated macrophages in hematological malignancies.Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma.Role of tumor-associated macrophages in human malignancies: friend or foe?Regulatory myeloid cells: an underexplored continent in B-cell lymphomas.CD68/macrosialin: not just a histochemical marker.The role of tumour-infiltrating eosinophils, mast cells and macrophages in Classical and Nodular Lymphocyte Predominant Hodgkin Lymphoma in children.Pediatric Hodgkin lymphoma in a South Indian regional cancer center: its immunomorphology, tumor-associated macrophages, and association with Epstein-Barr virus.Early interim 2-(1)fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to peripheral blood lymphocyte/monocyte ratio at diagnosis in classical Hodgkin's lymphoma.CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma.Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma.Spindle-shaped CD163+ rosetting macrophages replace CD4+ T-cells in HIV-related classical Hodgkin lymphoma.Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma.Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma.An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.The Lymphocyte-Monocyte Ratio and the Platelet-Lymphocyte Ratio at Diagnosis as Independent Prognostic Factors in Primary Gastrointestinal Diffuse Large B Cell Lymphoma.Prognostic impact of monocyte count at presentation in mantle cell lymphoma.Tumor-associated macrophages as a prognostic parameter in multiple myeloma.Interleukin 10 (IL10) proximal promoter polymorphisms beyond clinical response in classical Hodgkin lymphoma: Exploring the basis for the genetic control of the tumor microenvironment.Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment.CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment.Prognostic significance of Bcl-2, tumor-associated macrophages, and total neoplastic and inflammatory lymph node involvement in advanced stage classical Hodgkin's lymphoma.The heterogenic tumor microenvironment of hepatocellular carcinoma and prognostic analysis based on tumor neo-vessels, macrophages and α-SMA.
P2860
Q28083973-76F75BEE-5CE3-48C5-B63E-D0AB9156B2DFQ30449589-6AFB0172-4989-4550-ABFE-CA11FDC17B3DQ31111207-E1007E14-1A84-428D-8062-3D04E17D2B62Q34507403-E58A53B6-C901-45BD-B200-B4D993CE88F7Q34627838-78E6894B-89BA-41F7-BF4F-A4EE83409E95Q34998148-7B72D34F-C23F-4318-BA7C-BB9EEBDC5B1CQ35661295-594F66EC-0A28-49F2-9C08-C42A2D75ABBEQ35763447-6B60A420-3127-4C4F-B1E9-B85B7B974160Q35779386-DC1677C6-8A2E-4A80-A8FC-11F1277B2952Q36094731-6AEDC0D9-7C10-4580-8798-ED02B0F64951Q36164491-63BC8EDD-8C68-407F-BAC8-3CD1867BB2C9Q36333526-916F2DF5-FA50-4958-B6E9-4103BED931F1Q36706850-AC5E7023-E0CD-4F6C-9F3E-BEA260D65127Q36973329-75A45FE0-8873-4B4A-9ED4-4DA605314900Q37969227-08D08A66-7A0F-4902-9F77-2C2B00629A02Q37987661-26948F2E-8E1E-4A01-AA11-7DCC5E026FEFQ38364405-7CE5743F-3B9A-4C11-AD4A-9A6F832B8E6FQ38557033-09963764-E73F-4E13-A7F0-237276E3A802Q38904869-87447261-5B9E-4C0F-B968-0DA0E0F1203CQ39423479-29D5CFAA-FB11-463C-9498-E6B292D6EA9AQ40442574-D7CB7589-2278-4AF6-B906-6742BC38311CQ40912853-F7FBE6B1-1AE2-4234-97DA-6424712D99CAQ41727799-46EE4A7C-8116-429D-B116-1DF543FFCEF6Q43188757-0D5499B0-90F6-4FE0-8F81-65BEE056E17CQ43727060-C14D2B25-FDC1-478D-9BD1-79327BDFB31EQ45231156-EF726599-6F74-4210-B8E7-96629F9F4637Q45364817-88335DBA-628C-48A6-99D6-3549A388DA93Q45387203-7D56D960-B3A9-4D34-8C45-58BAB3716A32Q46693258-341DAD32-7776-4C67-8843-3EF7C05A842EQ47437693-5677E8DE-D2DE-4098-ACC4-6F6A7A1434C6Q47602259-0B09E3D8-E06A-48EB-B2B9-ABB3F7A1D973Q48212629-82B287C9-7C85-449C-93A4-F9C3C77839DCQ50798505-B4CC3654-F88D-4FBA-BF19-F196AEA8CBA6Q50878568-A4C647A6-95C3-4C80-B99F-5B3520F3B380Q52803465-B10C3239-E3AA-49CC-990B-5E8EC6D7B678Q52926177-C5FB1FAC-2F92-4ADD-85F6-0186DECB9FBDQ53068100-62859C24-0F38-4E10-9D74-E77D9B3CF718Q53119739-79C13BF9-64EB-4C7D-8ED1-9F5AC74E9C59Q55002211-802778FD-BA17-441E-A023-A6888CC4E129
P2860
Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Lack of association of tumor-a ...... classical Hodgkin's lymphoma.
@ast
Lack of association of tumor-a ...... classical Hodgkin's lymphoma.
@en
type
label
Lack of association of tumor-a ...... classical Hodgkin's lymphoma.
@ast
Lack of association of tumor-a ...... classical Hodgkin's lymphoma.
@en
prefLabel
Lack of association of tumor-a ...... classical Hodgkin's lymphoma.
@ast
Lack of association of tumor-a ...... classical Hodgkin's lymphoma.
@en
P2093
P2860
P356
P1433
P1476
Lack of association of tumor-a ...... classical Hodgkin's lymphoma.
@en
P2093
D Azambuja
I S Lossos
J C Morais
M W Anderson
Y Natkunam
P2860
P304
P356
10.1093/ANNONC/MDR157
P577
2011-05-20T00:00:00Z